Support every development stage, from target identification to lead optimisation, to achieve a preclinical proof of concept
We know that the biotech sector is highly characterised, relative to others, by a predominant technological and scientific risk
It is for this reason that we stick with the research teams on the entire development process, crafting with them a tailored project plan that meets the business and scientific needs of every initiative so that we can be ready to face every obstacle along the way and achieve the pre agreed milestones. As part of our strategy, we believe that financing in tranches reduces risks and makes the small progression steps that compose an overall successful path, efficient.
Decisions are taken by the board of EXTEND which counts more than 50 cumulative years of experience between the 3 members with skills posed at the intersection of finance and science.